Analyzing Cavitation Technologies (CVAT) & Marrone Bio Innovations (MBII)

Cavitation Technologies (OTCMKTS:CVAT) and Marrone Bio Innovations (NASDAQ:MBII) are both basic materials companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, institutional ownership, dividends, earnings, analyst recommendations and valuation.

Institutional and Insider Ownership

23.2% of Marrone Bio Innovations shares are owned by institutional investors. 2.9% of Marrone Bio Innovations shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares Cavitation Technologies and Marrone Bio Innovations’ revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Cavitation Technologies N/A N/A N/A N/A N/A
Marrone Bio Innovations $18.17 million 9.49 -$30.92 million ($1.07) -1.46

Cavitation Technologies has higher earnings, but lower revenue than Marrone Bio Innovations.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Cavitation Technologies and Marrone Bio Innovations, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cavitation Technologies 0 0 0 0 N/A
Marrone Bio Innovations 0 1 1 0 2.50

Marrone Bio Innovations has a consensus price target of $2.78, suggesting a potential upside of 77.88%. Given Marrone Bio Innovations’ higher possible upside, analysts clearly believe Marrone Bio Innovations is more favorable than Cavitation Technologies.

Profitability

This table compares Cavitation Technologies and Marrone Bio Innovations’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Cavitation Technologies N/A N/A N/A
Marrone Bio Innovations -136.35% N/A -54.13%

Summary

Marrone Bio Innovations beats Cavitation Technologies on 5 of the 7 factors compared between the two stocks.

Cavitation Technologies Company Profile

Cavitation Technologies, Inc. develops, patents, and commercializes proprietary technology for use in liquid processing applications in the United States. It offers Nano Neutralization system for refining vegetable oils, such as soybean, rapeseed, and canola oil. The company also designs technology based systems that are designed to serve various markets, such as vegetable oil refining, renewable fuels, water treatment, wines and spirits enhancement, algae oil extraction, water-oil emulsions, and crude oil yield enhancement. Cavitation Technologies, Inc. was founded in 2007 and is headquartered in Chatsworth, California.

Marrone Bio Innovations Company Profile

Marrone Bio Innovations, Inc. provides bio-based pest management and plant health products primarily for agricultural and water markets in the United States and internationally. It offers herbicides; fungicides; nematicides; insecticides; algaecides for algae control; molluscicides for mussel and snail control; plant growth and stress regulators; and water treatment products for various applications, such as hydroelectric and thermoelectric power generation, industrial applications, drinking water, aquaculture, irrigation, and recreation. The company's products include Regalia, a plant extract-based fungicidal biopesticide for plant disease control and plant health; and Grandevo, a bioinsecticide for insect and mite control to the growers of specialty crops, such as grapes, citrus, tomatoes, vegetables, nuts, leafy greens, and ornamental plants. It also provides Zequanox, a biomolluscicide that controls invasive mussels, which cause infrastructure and ecological damage primarily to power and industrial companies; and Venerate, a bioinsecticide, which controls chewing and sucking insects and mites, as well as flies and plant parasitic nematodes. In addition, the company offers Haven, an sun protectant product that reduces plant stress and dehydration; and Majestene and Zelto, a bionematicide to control soil-dwelling nematodes by preventing and reducing root galls, as well as reducing adult reproduction and egg hatch. Further, it provides Stargus and Amplitude, a biofungicide for improving plant health. Marrone Bio Innovations, Inc. provides its products directly through sales force, as well as through distributors. The company formerly known as Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc. was founded in 2006 and is headquartered in Davis, California.

Receive News & Ratings for Cavitation Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cavitation Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply